Table 1.
TCGA cancer types*
| Tumour type | TCGA code | Number of cases with-Omic data† | Number of cases with digital pathology images |
|---|---|---|---|
| Haematopoietic | |||
| Acute myeloid leukaemia | AML | 191 | NA |
| Diffuse large B-cell lymphoma | DLBC | 48 | 48 |
| Thymoma | THYM | 124 | 124 |
| Gynaecological | |||
| Cervical squamous cell carcinoma Endocervical adenocarcinoma | CESC | 307 | 308 |
| Uterine carcinosarcoma | UCS | 57 | 57 |
| Uterine corpus endometrial carcinoma | UCEC | 559 | 560 |
| Ovarian serous cystadenocarcinoma | OV | 608 | 590 |
| Urinary tract | |||
| Bladder urothelial carcinoma | BLCA | 412 | 412 |
| Renal chromophobe carcinoma | KICH | 66 | 113 |
| Clear cell renal cell carcinoma | KIRC | 535 | 537 |
| Papillary renal cell carcinoma | KIRP | 291 | 291 |
| Prostate/testis | |||
| Prostate adenocarcinoma | PRAD | 498 | 500 |
| Testicular germ cell tumours | TGCT | 150 | 150 |
| Endocrine | |||
| Thyroid carcinoma | THCA | 507 | 507 |
| Adrenocortical carcinoma | ACC | 92 | 92 |
| Phaeochromocytoma Paraganglioma | PCPG | 179 | 179 |
| Breast | |||
| Breast invasive carcinoma | BRCA | 1098 | 1103 |
| Gastrointestinal tract | |||
| Oesophageal carcinoma | ESCA | 185 | 185 |
| Stomach adenocarcinoma | STAD | 443 | 478 |
| Colonic adenocarcinoma | COAD | 460 | 462 |
| Rectal adenocarcinoma | READ | 171 | 283 |
| Liver, pancreaticobiliary | |||
| Cholangiocarcinoma | CHOL | 36 | 39 |
| Hepatocellular carcinoma | LIHC | 377 | 377 |
| Pancreatic adenocarcinoma | PAAD | 185 | 191 |
| Pulmonary | |||
| Lung adenocarcinoma | LUAD | 585 | 523 |
| Lung squamous cell carcinoma | LUSC | 504 | 512 |
| Mesothelioma | MESO | 87 | 87 |
| Head and neck | |||
| Head and neck squamous cell carcinoma | HNSC | 528 | 523 |
| Melanocytic malignancies | |||
| Cutaneous melanoma | SKCM | 470 | 471 |
| Uveal melanoma | UVM | 80 | 80 |
| Brain | |||
| Lower-grade glioma | LGG | 516 | 521 |
| Glioblastoma multiforme | GBM | 617 | 613 |
| Mesenchymal | |||
| Adult soft tissue sarcoma | SARC | 261 | 261 |
*
From https://portal.gdc.cancer.gov (accessed 27 October 2017).
†
Numbers of cases reflect the total with data, including cases excluded from TCGA analyses for quality control or pathology review. -Omic data for these studies includes genomic, transcriptomic, epigenomic, and/or proteomic data. Not all cases with data were analysable across all platforms.